Evidence map›Paper›PMID 22855121›Full record

ArticleAnnals of biomedical engineering2013

Microfluidic system for facilitated quantification of nanoparticle accumulation to cells under laminar flow.

Jiro Kusunose, Hua Zhang, M Karen J Gagnon, Tingrui Pan, Scott I Simon, Katherine W Ferrara

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Microfluidic T Cell Selection by Cellular Avidity.Advanced healthcare materials · 2022
    Article
  3. Multi-oscillation microrheologyLab on a chip · 2021
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Experimental biology and medicine (Maywood, N.J.) · 2016
    Review
  9. Review
  10. Review
  11. Article
  12. Synthetic tumor networks for screening drug delivery systems.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  13. Article
  14. Organ-on-a-chip platforms for studying drug delivery systems.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiro KusunoseDepartment of Biomedical Engineering, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA. jkusunose@ucdavis.edu
Hua Zhang
M Karen J Gagnon
Tingrui Pan
Scott I Simon
Katherine W Ferrara

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Ultrasound Imaging and Local Drug Delivery in TumorsR01CA103828 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W · 2004 to 2013
$10.4M
Outside-in Mechanotransduced Inflammatory TargetsR01AI047294 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SIMON, SCOTT IRWIN · 1999 to 2021
$7.0M
Specific and high-resolution ultrasound cancer imagingR01CA112356 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W, FOIRET, JOSQUIN · 2005 to 2022
$6.1M
Vascular Mimetics to Study Inflammation and AtherosclerosisR01HL082689 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PASSERINI, ANTHONY G., SIMON, SCOTT IRWIN · 2008 to 2016
$3.2M
Engineering Approaches to Molecular Imaging TrainingT32EB003827 · NIBIB · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W · 2004 to 2013
$1.6M
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA103828NCI NIH HHS R01CA103828NCI NIH HHS R01 CA112356NHLBI NIH HHS HHSN268201000043CNHLBI NIH HHS R01 HL082689NIAID NIH HHS R01 AI047294NIBIB NIH HHS T32 EB003827NIBIB NIH HHS T32EB003827
6 · The paper itself

Abstract

The identification of novel, synthetic targeting ligands to endothelial receptors has led to the rapid development of targeted nanoparticles for drug, gene and imaging probe delivery. Central to development and optimization are effective models for assessing particle binding in vitro. Here, we developed a simple and cost effective method to quantitatively assess nanoparticle accumulation under physiologically-relevant laminar flow. We designed reversibly vacuum-sealed PDMS microfluidic chambers compatible with 35 mm petri dishes, which deliver uniform or gradient shear stress. These chambers have sufficient surface area for facile cell collection for particle accumulation quantitation through FACS. We tested this model by synthesizing and flowing liposomes coated with APN (K (D) ~ 300 μM) and VCAM-1-targeting (K (D) ~ 30 μM) peptides over HUVEC. Particle binding significantly increased with ligand concentration (up to 6 mol%) and decreased with excess PEG. While the accumulation of particles with the lower affinity ligand decreased with shear, accumulation of those with the higher affinity ligand was highest in a low shear environment (2.4 dyne/cm(2)), as compared with greater shear or the absence of shear. We describe here a robust flow chamber model that is applied to optimize the properties of 100 nm liposomes targeted to inflamed endothelium.

Indexed as

MicrofluidicsNanoparticlesAntibodies, MonoclonalCD13 AntigensHumansHuman Umbilical Vein Endothelial CellsLigandsLiposomesOligopeptidesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1Antibodies, MonoclonalCD13 AntigensLigandsLiposomesOligopeptidesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1

Identifiers

PMID22855121
PMCPMC3505813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.